Connect with us
Able has designed a robotic exoskeleton for people with disabilities. In Germany, Able's CEO highlights the fact that the company has carried out part of the...
The company, founded in 2015, although the project started in 2017, raised $601,000 (€600,000)in January 2021 to start the process of clinical validation of its device....
Moderna is now advancing two bivalent candidates for fall, based on differing market preferences for Omicron subvariants. The bivalent booster mRNA-1273.214 is the only candidate that...
Efpia's report highlights that in 2021 China almost equaled Europe as the region where new drugs were discovered and launched, with 18 and 19 new drugs,...
With the capital raised, Nimble will complete the preclinical testing phase, incorporate regulation and hire personnel. In addition, the company intends to test its tool within...
Currently, Dedalus has a presence in the UK and Ireland, Northern Europe, Austria, Switzerland, Spain, China, Brazil, Australia, New Zealand, and several locations in Latin America,...
Delta Med is also active in the production and distribution in Italy and abroad of medical devices and disposable accessories for infusion therapies, procedural kits for...
In Spain, 17,000 people die every year from different types of septicemia. This condition is one of the most serious diseases in the health system, since...
PBEs have doubled the number of clinical trials in the last five years, and their success rates are higher than those of their 'big sisters', according...
Satellos Bioscience is developing stem cell signaling pharmaceuticals that could reshape the way we treat muscular dystrophies like Duchenne muscular dystrophy (DMD). Its work is based...
 |
|
 |  |
 |
|